Abstract
Antidepressants or stimulants are commonly used to treat attention deficit disorder (ADD). We report the results of an open-label trial of the recently marketed antidepressant venlafaxine in 16 adult patients with ADD. Patients were treated with venlafaxine (25 to 225 mg/day) for 8 weeks. Four patients discontinued treatment within the first week because of sedation, agitation, or nausea. In the remaining 12 patients, venlafaxine treatment decreased ADD ratings by almost half.
| Original language | English |
|---|---|
| Pages (from-to) | 785-788 |
| Number of pages | 4 |
| Journal | Psychopharmacology Bulletin |
| Volume | 31 |
| Issue number | 4 |
| State | Published - 1995 |
| Externally published | Yes |
Keywords
- adult ADHD
- antidepressant
- attention deficit disorder
- hyperactivity
- venlafaxine